|
W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
| Catalog Number |
VBHR130502A |
| Medical Device Problem Code |
Detachment of Device or Device Component (2907)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/25/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6 - code b23: device has been requested, but has not been returned for evaluation.H6 - code c19: a review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2025, a patient underwent treatment for an aneurysmal popliteal artery.It was reported a v-18 boston 0.018" guidewire was used to advance a gore® viabahn® endoprosthesis with heparin bioactive surface viabahn device over a gore® dryseal flex introducer sheath.A 10mm x 15cm viabahn device was implanted in the distal popliteal artery without complication and successful implantation was achieved.Next, a 13mm x 5cm viabahn device was advanced and deployed.However, during post-dilation, it was realized the distal tip of the 13mm x 5cm viabahn delivery system had migrated into the peroneal artery.Using a snare, the distal tip was retrieved.The physician confirmed that no foreign material remained in the patient.After post dilation using a medtronic evercross balloon, the procedure was completed with good results.The patient did not experience any adverse consequences.As reported, the catheter appeared to have a clean break, suggesting the catheter may have been severed prior to insertion.No excessive force was applied during the procedure.The patient did not experience any adverse consequences.
|
| |
|
Additional Manufacturer Narrative
|
|
Section h6 updated to reflect completion of investigation.Removed code d16 and added code d15.A review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.The device was requested but got discarded at the facility, therefore, not available for analysis.No clinical images enabling direct assessment of product performance were returned for evaluation.Cause of the reported event cannot be established based on the information reported to gore.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.
|
| |
|
Search Alerts/Recalls
|
|
|